SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma

Current approaches in identification and isolation of cancer stem cells

(2019) Maryam Akbarzadeh et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cancer cells stemness: A doorstep to targeted therapy

(2019) Sahdeo Prasad et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma

(2019) Saei et al.   Cancers

SP1-induced upregulation of lncRNA PANDAR predicts adverse phenotypes in retinoblastoma and regulates cell growth and apoptosis in vitro and in vivo

(2018) Lijie Sheng et al.   GENE

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

(2018) Lan Thi Hanh Phi et al.   Stem Cells International

ABC transporters as cancer drivers: Potential functions in cancer development

(2018) Alice Domenichini et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

(2018) Lynn Roy et al.   Cancers

Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?

(2017) Constance E. Brinckerhoff   JOURNAL OF CELLULAR PHYSIOLOGY

Decreased miR-128 and increased miR-21 synergistically cause podocyte injury in sepsis

(2017) Shanshan Wang et al.   JOURNAL OF NEPHROLOGY

Epigenetics in cancer stem cells

(2017) Tan Boon Toh et al.   Molecular Cancer

Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells

(2017) Pritha Mukherjee et al.   Scientific Reports

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy

(2016) Michael P. Smith et al.   CANCER CELL

Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance

(2016) M. P. Smith et al.   CLINICAL CANCER RESEARCH

Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors

(2016) Gao Zhang et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

(2016) Aaron N Hata et al.   NATURE MEDICINE

The role of ABC transporters in ovarian cancer progression and chemoresistance

(2015) M.P. Ween et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Overcoming Multidrug Resistance in Cancer Stem Cells

(2015) Karobi Moitra   Biomed Research International

Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells

(2014) Harris Wang et al.   BMC CANCER

Importance of ABCC1 for cancer therapy and prognosis

(2014) Tereza Kunická et al.   DRUG METABOLISM REVIEWS

SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells

(2014) R Santini et al.   ONCOGENE

Tumor adaptation and resistance to RAF inhibitors

(2013) Piro Lito et al.   NATURE MEDICINE

The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis

(2013) Jasper Wouters et al.   PLoS One

Side Population Cells as Prototype of Chemoresistant, Tumor-Initiating Cells

(2013) Vinitha Richard et al.   Biomed Research International

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance

(2012) Yuchun Luo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2

(2011) H.-M. Jeon et al.   CANCER RESEARCH

Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma

(2010) A. Y. Bedikian et al.   ANNALS OF ONCOLOGY

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

(2010) Alexander Roesch et al.   CELL

Identification of cells initiating human melanomas

(2008) Tobias Schatton et al.   NATURE